November 2016 FDA Recall Metformin Hydrochloride by Ascend Laboratories Llc
D-0163-2017 - Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP

This Class II drug recall was voluntarily initiated by Ascend Laboratories Llc on November 2, 2016 for the product Metformin Hydrochloride. The FDA reported the reason for recall as presence of foreign tablets/capsules; report of amlodipine tablets found in 1000 count bottles of metformin hydrochloride tablets usp. The product was distributed in AL, FL, GA, SC & TN and the recall is currently terminated.

Recall Number: D-0163-2017

Reason for Recall
Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP
Initiated
11-02-2016
Reported
12-07-2016
Quantity
1739 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Ascend Laboratories LLC
AL, FL, GA, SC & TN
Metformin Hydrochloride Tablets, USP 500 mg, 1000 tablets, Rx Only Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Montvale, NJ NDC 67877-217-10

Batch or Lot Expiration Information

Lot# Lot 6121056, exp 5/2019